FIELD: medicine.
SUBSTANCE: treatment or prevention of epithelial disorders mediated by microorganisms, such as enterogenous sepsis, burns, necrotising enterocolitis and many other pathological conditions, is ensured with polyethylene glycol of molecular weight 8000-20000 dalton applied as an active agent in methods and pharmaceutical compositions, and for production of medical products. Polyethylene glycol of specified molecular weight provides complete inhibition of virulence manifestation of microorganisms, including Pseudomonas aeruginosa, without destruction thus preserving individual natural microflora.
EFFECT: higher efficiency.
36 cl, 6 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYSTEM FOR CELL CULTURING | 2012 |
|
RU2612915C2 |
| PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
| COMPOSITION BASED ON NANOPARTICLES WITH IMPROVED PENETRATION THROUGH MUCOUS MEMBRANES | 2013 |
|
RU2598627C2 |
| NEW SUBSTANCES BINDING TO HELICOBACTER PILORI AND USES THEREOF | 2000 |
|
RU2283115C2 |
| LACTOBACILLUS SALIVARIUS VKSHM-G-08PD STRAIN | 2024 |
|
RU2822455C1 |
| IMPROVING ABSORPTION OF THERAPEUTIC AGENTS THROUGH MUCOUS MEMBRANES OR SKIN | 2009 |
|
RU2519193C2 |
| STRAIN LACTOBACILLUS GASSERI AND BACTERIAL DRUG WITH HYPOCHOLESTERYNAMIC AND ANTI-INFLAMMATORY IMMUNOMODULATING ACTIVITIES | 2012 |
|
RU2672571C1 |
| POLYBACTERIAL DRUG WITH ADVANTAGES FOR HEALTH: WITH ANTIOXIDANT EFFECT, DECREASED CHOLESTEROL CONCENTRATION, ANTI-INFLAMMATORY AND IMMUNO-MODULATING EFFECT, AND RELEASE OF BIOACTIVE PEPTIDES INHIBITING ANGIOTENSIN-CONVERTING ENZYME | 2012 |
|
RU2627651C2 |
| NOVEL PEPTIDES AND METHODS FOR PRODUCTION THEREOF | 2010 |
|
RU2583579C2 |
| REMEDY INHIBITING BINDING OF S, PNEUMONIAE OR/AND H,INFLUENZAE AND COMPOSITION HAVING THE REMEDY | 1991 |
|
RU2035913C1 |
